AptarGroup (ATR) announced the commencement of a clinical study to validate its proprietary SmartTrack platform. The platform was developed by ...

Aptar Digital Health today announced survey findings showcasing the impact of its iPump connected assistant for medication ...

AptarGroup is poised for growth in its Pharma and Closure segments, but challenges are expected in the Beauty segment. See ...

Conduit Pharmaceuticals (CDT) announces the filing of two groundbreaking patents for tapinarof, VTAMA, including a dual active cocrystal, ...

2024 (which was uploaded on NCLT website on November 19, 2024) sanctioning the Scheme of Arrangement for creation of Onesource, India''s first specialty pharma CDMO.

Biotech companies create drugs from living organisms, requiring a BLA for FDA approval. Pharma companies develop drugs from chemicals, needing an NDA for FDA approval. Many firms blend biotech and ...

President Donald Trump announced upcoming tariffs on the pharmaceutical industry, without elaborating on specifics. He also mentioned being open to negotiating deals with other countries after ...

Digitalisation of health is one of Chiesi's core R&D objectives, and the alliance with Aptar isn't its first in the respiratory category, its largest therapeutic area accounting for €1.7 billion ...

U.S. President Donald Trump signs an executive order about tariffs increase in the Oval Office of the White House in Washington, D.C. Kevin Lamarque/Reuters President Donald Trump has announced ...

CEOs from large pharma companies AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, GSK, Merck KGaA, Pfizer and Sanofi were among more than 40 international business leaders who met with Xi in ...

Potential US tariffs on pharmaceuticals could set off a ripple effect that extends far beyond the immediate price hikes, as both the US and Europe heavily rely on each other. The world's holding ...